Fuller & Thaler Asset Management
CNMD icon

Fuller & Thaler Asset Management’s CONMED CNMD Stock Holding History

Fuller & Thaler Asset Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.7M Sell
1,579,917
-61,849
-4% -$2.23M 0.14% 225
2026
Q1 		$58.1M Buy
1,641,766
+50,176
+3% +$2.04M 0.2% 166
2025
Q4 		$64.6M Sell
1,591,590
-143,238
-8% -$6.23M 0.22% 173
2025
Q3 		$81.6M Sell
1,734,828
-5,802
-0.3% -$301K 0.28% 128
2025
Q2 		$90.7M Buy
1,740,630
+566,598
+48% +$31.1M 0.33% 104
2025
Q1 		$70.9M Buy
1,174,032
+311,288
+36% +$20.1M 0.28% 133
2024
Q4 		$59M Buy
+862,744
New +$60.1M 0.22% 152

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Fuller & Thaler Asset Management's CNMD Position: Q2 2026 in Review

Fuller & Thaler Asset Management reduced its CONMED (CNMD) stake by 3.8% in Q2 2026, selling an estimated $2.23M and leaving 1,579,917 shares worth $51.7M. The position accounts for 0.14% of the portfolio, ranked #225.

Fuller & Thaler Asset Management first reported a position in CNMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $90.7M in Q2 2025. 182 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Fuller & Thaler Asset Management held 1,579,917 shares of CONMED worth $51.7M as of Q2 2026.
  • Fuller & Thaler Asset Management sold 61,849 CONMED shares in Q2 2026, an estimated $2.23M.
  • CONMED made up 0.14% of Fuller & Thaler Asset Management's portfolio in Q2 2026, its #225 holding.
  • Fuller & Thaler Asset Management first reported a position in CONMED in Q4 2024 and has held it in 7 quarters since.
  • Fuller & Thaler Asset Management's CONMED position peaked at $90.7M in Q2 2025.
  • 182 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.